<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Herring N</submitter><funding>NIH SPARC</funding><funding>British Heart Foundation</funding><funding>NIDDK NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>National Institutes of Health</funding><funding>Health Research Council, Marsden Fund, the Royal Society of New Zealand and the Sidney Taylor Trust</funding><funding>NIH HHS</funding><pagination>1729-1779</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11955874</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>603(7)</volume><pubmed_abstract>In our original white paper published in the The Journal of Physiology in 2016, we set out our knowledge of the structural and functional organization of cardiac autonomic control, how it remodels during disease, and approaches to exploit such knowledge for autonomic regulation therapy. The aim of this update is to build on this original blueprint, highlighting the significant progress which has been made in the field since and major challenges and opportunities that exist with regard to translation. Imbalances in autonomic responses, while beneficial in the short term, ultimately contribute to the evolution of cardiac pathology. As our understanding emerges of where and how to target in terms of actuators (including the heart and intracardiac nervous system (ICNS), stellate ganglia, dorsa</pubmed_abstract><journal>The Journal of physiology</journal><pubmed_title>Neurocardiology: translational advancements and potential.</pubmed_title><pmcid>PMC11955874</pmcid><funding_grant_id>R01 HL116476</funding_grant_id><funding_grant_id>R01HL150136</funding_grant_id><funding_grant_id>FS/SCRF/20/32005</funding_grant_id><funding_grant_id>U54AT012307</funding_grant_id><funding_grant_id>R21 DK128663</funding_grant_id><funding_grant_id>R01HL162921</funding_grant_id><funding_grant_id>RG/19/5/34 463</funding_grant_id><funding_grant_id>P01HL164311</funding_grant_id><funding_grant_id>1OT2OD023848</funding_grant_id><funding_grant_id>FS/SCRF/20/32 005</funding_grant_id><pubmed_authors>Osborn J</pubmed_authors><pubmed_authors>Ardell JL</pubmed_authors><pubmed_authors>Ripplinger CM</pubmed_authors><pubmed_authors>Smith C</pubmed_authors><pubmed_authors>Vrabec TL</pubmed_authors><pubmed_authors>Herring N</pubmed_authors><pubmed_authors>Ajijola OA</pubmed_authors><pubmed_authors>Foreman RD</pubmed_authors><pubmed_authors>Paterson DJ</pubmed_authors><pubmed_authors>Zucker IH</pubmed_authors><pubmed_authors>Paton JFR</pubmed_authors><pubmed_authors>Gourine AV</pubmed_authors><pubmed_authors>Green AL</pubmed_authors><pubmed_authors>Wang HJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Neurocardiology: translational advancements and potential.</name><description>In our original white paper published in the The Journal of Physiology in 2016, we set out our knowledge of the structural and functional organization of cardiac autonomic control, how it remodels during disease, and approaches to exploit such knowledge for autonomic regulation therapy. The aim of this update is to build on this original blueprint, highlighting the significant progress which has been made in the field since and major challenges and opportunities that exist with regard to translation. Imbalances in autonomic responses, while beneficial in the short term, ultimately contribute to the evolution of cardiac pathology. As our understanding emerges of where and how to target in terms of actuators (including the heart and intracardiac nervous system (ICNS), stellate ganglia, dorsa</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar</publication><modification>2026-06-03T05:56:13.292Z</modification><creation>2026-04-25T03:16:37.951Z</creation></dates><accession>S-EPMC11955874</accession><cross_references><pubmed>39340173</pubmed><doi>10.1113/JP284740</doi></cross_references></HashMap>